Contribution of adverse events to death of hospitalised patients
Background There is no standardised method to investigate death as a patient safety indicator and we need valid and reliable measurements to use adverse events contributing to death as a quality measure.Objective To investigate the contribution of severe adverse events to death in hospitalised patie...
Saved in:
| Main Authors: | Ellinor Christin Haukland, Kjersti Mevik, Christian von Plessen, Carsten Nieder, Barthold Vonen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-01-01
|
| Series: | BMJ Open Quality |
| Online Access: | https://bmjopenquality.bmj.com/content/8/1/e000377.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway – a national register-based cohort study
by: Elin Marthinussen Gustavsen, et al.
Published: (2024-12-01) -
Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD
by: Ioannides AE, et al.
Published: (2025-07-01) -
‘Scared to death’ dyspnoea from the hospitalised patient’s perspective
by: Robert B B Banzett, et al.
Published: (2020-09-01) -
Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies
by: Martine de Bruijne, et al.
Published: (2020-09-01) -
Implementing digital patient-reported outcomes in routine cancer care: barriers and facilitators
by: S.G. Aanes, et al.
Published: (2024-12-01)